Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
156M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
47.3M
-
Shares change
-
+4.6M
-
Total reported value, excl. options
-
$148M
-
Value change
-
+$13.3M
-
Put/Call ratio
-
0.46
-
Number of buys
-
53
-
Number of sells
-
-30
-
Price
-
$3.14
Significant Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q4 2021
107 filings reported holding WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value as of Q4 2021.
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.3M shares
of 156M outstanding shares and own 30.38% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.78M shares), MAVERICK CAPITAL LTD (5.59M shares), Bellevue Group AG (4.6M shares), PRIMECAP MANAGEMENT CO/CA/ (4.59M shares), M28 Capital Management LP (3.77M shares), BlackRock Inc. (2.89M shares), Kynam Capital Management, LP (1.49M shares), PLATINUM INVESTMENT MANAGEMENT LTD (1.34M shares), D. E. Shaw & Co., Inc. (1.11M shares), and MILLENNIUM MANAGEMENT LLC (1.09M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.